共 50 条
- [1] Methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) combination therapy in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 3 years. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 578 - 578
- [2] Combination DMARD therapy with methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 5 years. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S132 - S132
- [4] Minocycline for early rheumatoid arthritis (RA): Results of a double-blind trial ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R4 - R4
- [5] Early aggressive therapy in the treatment of rheumatoid arthritis (RA). ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R23 - R23
- [6] Changes in employment, disability and retirement status in rheumatoid arthritis (RA) patients over 7 years. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1090 - 1090
- [7] Long term treatment with sulphasalazine in rheumatoid arthritis (RA): 351 patients followed for 10 years. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S144 - S144
- [8] Radiographic progression in rheumatoid arthritis (RA) patients treated with leflunomide (LEF) over two years. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S523 - S523
- [9] Autoantibodies in serum of blood donors precede symptoms of rheumatoid arthritis (RA) by 1 to 6 years. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S370 - S370